Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A critical appraisal of the role of the clinical microbiology laboratory in diagnosis of invasive fungal infections.J Clin Microbiol. 2011; 49: S39-S42
- Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis.Diagn Microbiol Infect Dis. 1993; 17: 103-109
- Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.Clin Pharmacol Ther. 2001; 69: 89-95
- Rat monoclonal antibodies against Aspergillus galactomannan.Infect Immun. 1992; 60: 2237-2245
- Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.Antimicrob Agents Chemother. 2001; 45: 857-869
- Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications.Clin Infect Dis. 2008; 46: 1412-1422
- Trial design for mold-active agents: time to break the mold—aspergillosis in neutropenic adults.Clin Infect Dis. 2007; 44: 1298-1306
- Utility of Aspergillus antigen detection in specimens other than serum specimens.Clin Infect Dis. 2004; 39: 1467-1474
- Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection.J Clin Microbiol. 2012; 50: 602-608
- Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.Clin Vaccine Immunol. 2008; 15: 1760-1763
- Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis.Br J Haematol. 2003; 121: 448-457
- Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing pulmonary aspergillosis in intensive care unit patients.Am J Respir Crit Care Med. 2008; 177: 27-34
- Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.Expert Rev Anti Infect Ther. 2011; 9: 289-298
- Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.J Clin Microbiol. 2000; 38: 3900-3901
- Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance.J Infect Dis. 2004; 190: 641-649
- False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.N Engl J Med. 2003; 349: 2366-2367
- Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection.Lancet. 2004; 363: 325-327
- Enteral nutrition may cause false-positive results of Aspergillus galactomannan assay in absence of gastrointestinal diseases.Mycoses. 2011; 54: e883-e884
- Galactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.J Clin Microbiol. 2011; 49: 4330-4332
- Galactomannan testing might be useful for early diagnosis of fusariosis.Diagn Microbiol Infect Dis. 2012; 72: 367-369
- Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species.J Clin Microbiol. 2012; 50: 3371-3373
- False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis.Transpl Infect Dis. 2012; 4: 213-217
- Cross-reactivity in the Platelia Aspergillus enzyme immunoassay caused by blastomycosis.Med Mycol. 2012; 50: 396-398
- Piperacillin/tazobactam (Tazocin) seems to be no longer responsible for false-positive results of the galactomannan assay.J Antimicrob Chemother. 2012; 67: 1746-1748
- Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.J Clin Microbiol. 2012; 50: 1258-1263
- Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.Clin Infect Dis. 2009; 49: 1688-1693
- Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.Clin Infect Dis. 2008; 46: 1813-1821
- Diagnosis of invasive fungal infections in hematology and oncology- guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).Ann Oncol. 2012; 23: 823-833
- Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.Clin Infect Dis. 2008; 46: 327-360
- New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients.Curr Opin Infect Dis. 2010; 23: 567-577
- Comparison of quantitative real-time PCR (Q-RT-PCR), galactomannan enzyme immunoassay (GM) and 1,3-beta-D-glucan detection (BG) in a guinea pig model of invasive aspergillosis. Abstract M-1696a. Abstracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September, 2009. In: Patterson TF. Clinical utility and development of biomarkers in invasive aspergillosis.Trans Am Clin Climatol Assoc. 2011; 122: 174-183
- Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition.Clin Infect Dis. 2011; 53: 671-676
- Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.Clin Infect Dis. 2008; 47: 674-683
- Observations on (1-3)-β-D-glucan detection as a diagnostic tool in endemic mycosis caused by Histoplasma or Blastomyces.J Med Microbiol. 2007; 56: 1001-1002
- Determination of plasma (1→3) β-D-glucan: a new diagnostic aid to deep mycosis.J Med Vet Mycol. 1992; 30: 275-280
- Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.Intern Med. 2011; 50: 2783-2791
- β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).Clin Infect Dis. 2012; 54: 633-643
- (1-3)-β-D-Glucan vs galactomannan antigen in diagnosing invasive fungal infections (IFIs).Open Microbiol J. 2012; 6: 70-73
- Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.J Clin Microbiol. 2005; 43: 299-305
- Reappraisal of the serum (1→3) β-D-glucan for the diagnosis of invasive fungal infections: a study based on autopsy cases from 6 years.Clin Infect Dis. 2008; 46: 1864-1870
- Comparative evaluation of (1,3)-β-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.BMC Infect Dis. 2007; 7: 103
- Prospective survey of (1→3) β-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.J Clin Microbiol. 2011; 49: 58-61
- Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.Intensive Care Med. 2012; 38: 1315-1325
- (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.Clin Infect Dis. 2012; 55: 521-526
- Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?.Crit Care. 2011; 15: 1017
- Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis.Clin Microbiol Infect. 2013; 19: 39-49
- Histoplasmosis as a cause for a positive Fungitell (1→3)-β-D-glucan test.Med Mycol. 2008; 46: 93-95
- Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?.Best Pract Res Clin Haematol. 2012; 25: 487-491
- Invasive mycoses: diagnostic challenges.Am J Med. 2012; 125: S14-S24
- The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.Crit Care. 2010; 14: R222
- Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Clin Infect Dis. 2009; 48: 503-535
- Contribution of serum biomarkers to the diagnosis of invasive candidiasis.Expert Rev Mol Diagn. 2008; 8: 315-325
- Diagnosis of disseminated candidiasis by measurement of urine D-arabinitol/L-arabinitol ratio.J Clin Microbiol. 1996; 34: 2175-2179
- PCR-based diagnosis of human fungal infections.Expert Rev Anti Infect Ther. 2009; 7: 1201-1221
- Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures.J Clin Microbiol. 2012; 50: 1446-1448
- Evaluation of the peptide nucleic acid fluorescence in situ hybridization technology for yeast identification directly from positive blood cultures: an Italian experience.Mycoses. 2012; 55: 388-392
- Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.Antimicrob Agents Chemother. 2005; 49: 3640-3645
- Detection of yeasts in blood cultures by the Luminex xTAG fungal assay.J Clin Microbiol. 2012; 50: 492-494
- Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi.J Clin Microbiol. 2011; 49: 3777-3782
- Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens.Med Mycol. 2012; 50: 775-780
- Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.Clin Infect Dis. 2011; 52: 1218-1226
- Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.Clin Infect Dis. 2012; 54: 1240-1248
- Evaluation of repetitive sequence PCR and PCR-mass spectrometry for the identification of clinically relevant Candida species.Med Mycol. 2012; 50: 259-265
- Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis.J Clin Microbiol. 2011; 49: 2169-2174
- Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to galactomannan enzyme immunoassay.J Clin Microbiol. 2011; 49: 4273-4278
- Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis.J Clin Microbiol. 2011; 49: 2252-2258
- Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.J Clin Microbiol. 2010; 48: 811-816
Great Basin Corporation. Available at: http://www.gbscience.com/. Accessed January 14, 2013.
RenDx Fungiplex panel. Available at: http://www.renishawdiagnostics.com/en/invasive-fungal-infection–17069. Accessed January 20, 2013.
T2 Biosystems. Available at: http://www.t2biosystems.com/Site/AboutUs/tabid/57/Default.aspx. Accessed January 20, 2013.
- Rapid real-time nucleic acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infections.J Clin Microbiol. 2009; 47: 2067-2078
- Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast.J Clin Microbiol. 2011; 49: 1614-1616
- Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system.J Clin Microbiol. 2011; 49: 2528-2532
- Successful identification of clinical dermatophyte and Neoscytalidium species by matrix-assisted laser desorption ionization -time of flight mass spectrometry.J Clin Microbiol. 2012; 50: 2277-2281
- Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization time of flight analyzer-mediated mass spectrometry.J Clin Microbiol. 2012; 50: 419-427
- Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.Cancer. 2011; 117: 3424-3433
- Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.J Antimicrob Chemother. 2012; 64: 2260-2267
- PCR diagnosis of invasive candidiasis: systematic review and meta-analysis.J Clin Microbiol. 2011; 49: 665-670
- Aspergillus PCR: one step closer to standardization.J Clin Microbiol. 2010; 48: 1231-1240
- Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.J Clin Microbiol. 2006; 44: 3381-3383
- Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures.Diagn Microbiol Infect Dis. 2006; 54: 277-282
- Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.J Clin Microbiol. 2012; 50: 823-830
- Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.Bone Marrow Transplant. 2010; 45: 17108
- Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome.Bone Marrow Transplant. 2009; 44: 595-599
- A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.Bone Marrow Transplant. 2009; 43: 553-561
- Fungal infections associated with contaminated methylprednisolone injections—preliminary report.N Engl J Med. 2012; ([Epub ahead of print])https://doi.org/10.1056/NEJMoa1213978
- Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network.J Clin Microbiol. 2009; 47: 3138-3141
- Cerebrospinal fluid (1,3) β-D-glucan detection as an aid to diagnose iatrogenic fungal meningitis.J Clin Microbiol. 2013; ([Epub ahead of print])https://doi.org/10.1128/JCM.00061-13
- Pathologic diagnosis of fungal infections.ASCP Press, Chicago1987
- Development and evaluation of nucleic acid-based techniques for an auxiliary diagnosis of invasive fungal infections in formalin-fixed and paraffin-embedded (FFPE) tissues.Med Mycol J. 2012; 53: 241-245
- Comparison of quantitative real time PCR with sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens.BMC Infect Dis. 2011; 11: 202
- Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR.J Clin Microbiol. 2010; 48: 2147-2153
Article info
Footnotes
The author has no disclosures to provide.
Identification
Copyright
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
